The IPO List
HomeListingsBlogsAboutJoin WhatsApp CommunityWhatsApp(Opens in a new tab)

The IPO List

Your trusted platform for IPO tracking and investment insights.

Quick Links

IPOsIPO ArchiveBlogsGMP AccuracyMethodologyAboutContact

Legal

Privacy PolicyTerms of ServiceDisclaimer

© 2026 The IPO List. All rights reserved.

  1. Home/
  2. IPO Calendar/
  3. Asston Pharmaceuticals IPO
Asston Pharmaceuticals
SMEListed

Asston Pharmaceuticals IPO

Bidding 9-11 Jul 2025, price band ₹115–123, lot 1000 shares.

OverviewGMPSubscriptionAllotment

Grey Market Premium Trend

GMP last updated: 16 Jul 2025, 9:30 AM IST

₹26
Final GMP
₹149
GMP-Implied Listing Price
21.1%
GMP-Implied Gain
₹115 - ₹123
Price Band

GMP History

DateGMP (₹)Est. Listing Price (₹)Est. Listing Gain
15 Jul₹26₹14921.14%
14 Jul₹26₹14921.14%
13 Jul₹25₹14820.33%
12 Jul₹30₹15324.39%
11 Jul₹30₹15324.39%
10 Jul₹30₹15324.39%
9 Jul₹30₹15324.39%
8 Jul₹25₹14820.33%
7 Jul₹15₹13812.20%
6 Jul₹10₹1338.13%
5 Jul₹10₹1338.13%
4 Jul₹10₹1338.13%
3 Jul₹10₹1338.13%

IPO timeline

  1. Issue open date
    9 Jul 2025
  2. Issue close date
    11 Jul 2025
  3. UPI mandate deadline
    11 Jul 2025
  4. Allotment finalization
    14 Jul 2025
  5. Refund initiation
    15 Jul 2025
  6. Share credit
    15 Jul 2025
  7. Listing date
    16 Jul 2025
  8. Mandate end date
    26 Jul 2025
  9. Lock-in end date for anchor investors (50%)
    13 Aug 2025
  10. Lock-in end date for anchor investors (remaining)
    12 Oct 2025

Asston Pharmaceuticals IPO Allotment Status

Allotment date:14 Jul 2025
Registrar:Maashitla Securities Private Limited
  1. Open the registrar's allotment page from the link below.
  2. Select Asston Pharmaceuticals from the list of companies.
  3. Enter your PAN, application number or demat account (DP/Client ID).
  4. Submit to see how many shares you were allotted.
Check allotment on Maashitla Securities(Opens in a new tab)BSE application status check(Opens in a new tab)

After allotment

Refund / mandate release:15 Jul 2025
Shares credited to demat:15 Jul 2025
Listing:16 Jul 2025
💸

IPO Subscription Status

CategoryTimesEst. Allotment Chances*
HNIs (Total)352.97🔥0.28%
QIBs85.76🔥-
Total185.73🔥-

*Rough estimate: 1 ÷ times subscribed. Retail and HNI allotment is by lottery, so actual odds depend on the number of applications.

Last updated: 11 July'25 10:09PM

Quick Stats

Issue Size:27cr
Lot Size:1000 shares
Min Investment (2 lots):₹2,46,000
P/E Ratio:17.83

About the Company

Asston Pharmaceuticals manufactures pharmaceutical formulations and nutraceutical products for domestic and African markets under the “Asston” brand. Operating from its Ambernath, Maharashtra facility, the company produces tablets, capsules, oral liquids, external preparations, and oral powders with a capacity of 8-9 crore tablets per month. The company maintains separate production floors for pharmaceutical and nutraceutical products to comply with FDA and FSSAI standards. Working with five WHO-GMP certified contract manufacturers, Asston holds over 150 registered trademarks and distributes products globally, particularly in South Africa and West African regions. Founded in 2019, the company operates with over 50 team members under experienced promoters.

Strengths

  • Promoters with 30+ years’ global pharma experience drive brand and compliance.
  • Diverse product portfolio across dosage forms strengthens global market adaptability.
  • Facilities strategically located near ports and airports, enabling efficient global exports.
  • Skilled workforce ensures quality compliance across outsourced manufacturing and distribution.
  • Strong relationships with WHO-GMP certified contract manufacturers ensure quality compliance.
  • Outsourced manufacturing enables asset-light operations with minimal regulatory or capex risks.

Risks

No risks provided as of now. Please check back later.

Asston Pharmaceuticals IPO – Frequently Asked Questions

  • The price band for the Asston Pharmaceuticals IPO is set at ₹115 to ₹123 per share.
  • The Asston Pharmaceuticals IPO opens on July 9, 2025 and closes on July 11, 2025.
  • The tentative listing date for the Asston Pharmaceuticals IPO is July 16, 2025.
  • The last recorded Grey Market Premium (GMP) for the Asston Pharmaceuticals IPO before listing was ₹26 (21.14%). GMP is unofficial and is not a guarantee of the listing price.
  • The Asston Pharmaceuticals IPO allotment date is July 14, 2025. Once it is finalised, check your status with your PAN or application number on the website of the registrar, Maashitla Securities Private Limited. Issues listed on BSE can also be checked on the BSE application status page.
  • You can apply for the Asston Pharmaceuticals IPO via your broker or bank using ASBA or UPI. Log in to your trading app (Zerodha, Upstox, Groww, etc.), select IPO section, choose Asston Pharmaceuticals, enter lot quantity and UPI ID, then approve the mandate.
  • The lot size for the Asston Pharmaceuticals IPO is 1000 shares. As an SME IPO, individual investors must apply for at least 2 lots (i.e., 2000 shares), which costs ₹2,46,000 at the upper price band.

Related IPOs

Open and upcoming

  • Friends Union for Energising Lives (FUEL)Bidding 11-20 Nov 2026
    Open
  • Crystal Crop ProtectionBidding 18-20 Nov 2026
    Open
  • Mahanadi CoalfieldsBidding 19-23 Nov 2026
    Upcoming
  • Watrana RentalsBidding 19-23 Nov 2026
    Upcoming

Recent SME listings

  • Antala IndustriesListed 11 Nov 2026
    -20%
  • Vedant Poly FabsListed 9 Nov 2026
    0%
  • Johnsoncab ElectricalsListed 6 Nov 2026
    +19.25%
  • HGS (India)Listed 6 Nov 2026
    +33.33%
  • Vectras EnproconListed 6 Nov 2026
    +0.95%
  • Maxwell Engineering SolutionsListed 6 Nov 2026
    +90%

All IPOs that opened in July 2025